Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis - Rossing, P; Anker, SD; Filippatos, G (Diabetes Care, 2022)
et al.